Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Inhibitors and reagents

YH Yu-Hao He
MY Ming-Hsin Yeh
HC Hsiao-Fan Chen
TW Tsu-Shing Wang
RW Ruey-Hong Wong
YW Ya-Ling Wei
TH Thanh Kieu Huynh
DH Dai-Wei Hu
FC Fang-Ju Cheng
JC Jhen-Yu Chen
SH Shu-Wei Hu
CH Chia-Chen Huang
YC Yeh Chen
JY Jiaxin Yu
WC Wei-Chung Cheng
PS Pei-Chun Shen
LL Liang-Chih Liu
CH Chih-Hao Huang
YC Ya-Jen Chang
WH Wei-Chien Huang
request Request a Protocol
ask Ask a question
Favorite

Carboplatin (41575-94-4), (Z)-4-hydroxy tamoxifen (68047-06-3), NMM (142234-85-3), and tetracycline (64-75-5) were all purchased from Cayman Chemical (Ann Arbor, MI, USA). Cisplatin (P4394), doxorubicin hydrochloride (Sigma-Aldrich; D1515), and auramine (Sigma-Aldrich; 492-80-8) were all purchased from Merck KGaA (Darmstadt, Germany). Clarity, Amersham, or Millipore enhanced chemiluminescence (ECL) was purchased from Bio-Rad Laboratories (Hercules, CA, USA), GE Healthcare Life Sciences (Pittsburgh, PA, USA), or Merck KGaA (Darmstadt, Germany), respectively.

Copyright and License information:  ©2021 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A